Clinical Trial Update: The CONFUCIUS Oral Protein Supplementation Trial [NA]

View source ↗

Summary

The study evaluating oral protein supplementation for ICU-acquired weakness and critical illness was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Intensive Care Unit Acquired Weakness

Drugs mentioned

• Oral protein supplementation (protein supplement)

Snippet

Sponsor: ARH van Zanten | Conditions: Intensive Care Unit Acquired Weakness, Critical Illness | NA | Status: TERMINATED